查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球體外心臟去顫器市場 -2023-2030
市場調查報告書
商品編碼
1374811

全球體外心臟去顫器市場 -2023-2030

Global External Defibrillators Market -2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

體外去顫器主要用於治療心室顫動（快速且不規則的心跳）和室性心動過速（致命的快速心跳）。作為一種緊急救生設備，它包括電池和電極片，可以檢測和分析患者的心律並提供電擊。

如果發生心臟驟停，成人可以使用自動體外心臟去顫器 (AED) 進行體外去顫。該設備提供有關如何檢查患者脈搏、呼吸和放置電極片的說明。 AED分析患者的心律，確定是否需要電擊，並在電擊後指導心肺復甦術。這個過程一直持續到救援人員到達並提供高級生命維持 (ALS) 治療為止。

AED 是一種電腦化去顫器，可以自動分析心臟驟停患者的心律。在適當的時候，它會對心臟進行電擊，以恢復其正常節律。 AED 系統包括電池和電極片等配件，這些配件是 AED 檢測和解釋人的心律並在需要時提供電擊所必需的。

市場動態：促進因素與限制因素

心律不整盛行率上升

心律不整很常見，但某些類型比其他類型更常見。最常見的是心房性早期心搏（PAC）和心房顫動。心房顫動影響大約五分之一的 65 歲以下美國人和大約十分之一的 65 歲以上美國人。室性心律不整的發生率差異很大。在一項研究中，每 10 萬名成年人中有 48 人（約 2,100 人中就有 1 人）發生室性心律不整。在老年人中，每100 名沒有任何已知危險因子的人中，就有2-3 人發生室性心律不整，每100 名患有冠狀動脈疾病(CAD) 的人中，有15-16 人發生室性心律不整。

預計政府、監管機構和醫療機構將推出越來越多的支持政策，這將在預測期內推動市場發展。例如，IRC（義大利復甦委員會）報告稱，義大利關於 AED 的擬議法律已於 2021 年 7 月獲得該商會社會事務委員會的批准。

此外，全球體外心臟去顫器市場受到技術進步、新穎產品發布以及與主要參與者的合作等多種因素的推動，將進一步推動預測期內的市場成長。

市場動態：克制

產品召回是預測期內阻礙市場成長率的主要因素之一。例如，2023 年7 月，美敦力召回了帶有玻璃饋通的植入式心律轉復除顫器(ICD) 和心臟再同步治療除顫器(crt-ds)，以應對高壓治療期間能量輸出低或無能量輸出的風險。

此外，嚴格的法規以及缺乏對心臟驟停（SAC）的認知和早期糾正措施等因素可能會阻礙預測期內市場的成長。此外，網路安全是除顫器市場的另一個主要問題。新一代植入式除顫器技術先進，可實現遠端資料傳輸。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按產品類型分類
  • 技術片段
  • 最終使用者的片段
  • 按地區分類

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 心律不整盛行率上升
      • 政府扶持政策不斷增多
    • 限制
      • 產品召回
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按產品類型

  • 自動體外心臟去顫器
  • 手動體外心臟去顫器
  • 穿戴式心臟復律去顫器

第 8 章：按技術

  • 單相除顫
  • 雙相除顫

第 9 章：最終用戶

  • 醫院
  • 診所
  • 居家照護服務
  • 門診手術中心

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • Koninklijke Philips NV
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Advin Health Care
  • ZOLL Medical Corporation
  • Defibtech, LLC.
  • Stryker
  • ClJ Medical System Inc.
  • Avive Solutions, Inc
  • Schiller AG
  • MEDIANA Co., Ltd
  • ViVest Medical Technology Co

第 13 章：附錄

簡介目錄
Product Code: MD7240

Overview

An external defibrillator is mainly used to treat ventricular fibrillation (fast and irregular heartbeat) and ventricular tachycardia (fatal rapid heartbeat). As an emergency life-saving device, it includes batteries and electrode pads that detect and analyze the patient's heart rhythm and deliver electrical shocks.

Adults can perform external defibrillation using an Automated External Defibrillator (AED) in case of a cardiac arrest. The device provides instructions on how to check the patient's pulse, breathe, and place electrode pads. The AED analyses the patient's heart rhythm, determines if a shock is needed, and guides through cardiopulmonary resuscitation after the shock. The process continues until help arrives to provide advanced life support (ALS) treatment.

AEDs are a type of computerized defibrillator that automatically analyzes the heart rhythm in people who are experiencing cardiac arrest. When appropriate, it delivers an electrical shock to the heart to restore its normal rhythm. The AED system includes accessories, such as a battery and pad electrodes, that are necessary for the AED to detect and interpret a person's heart rhythm and deliver an electrical shock if needed.

Market Dynamics: Drivers and Restraints

Rise in the Prevalence of cardiac arrhythmias

Arrhythmias are common, but some types are more common than others. The most common are premature atrial complexes (PACs) and atrial fibrillation. Atrial fibrillation affects about 1 in 50 Americans under the age of 65 and about 1 in 10 Americans over age 65. The incidence of ventricular arrhythmias varies widely. In one study, ventricular arrhythmias occurred in 48 per 100,000 adults (approximately 1 in 2,100 people). In older adults, ventricular arrhythmias occur in 2-3 out of 100 people who do not have any known risk factors, and in 15-16 in 100 people who have coronary artery disease (CAD).

An increasing number of supportive policies by governments, regulatory bodies, and healthcare organizations is anticipated to fuel the market over the forecast period. For example, the IRC (Italian Resuscitation Council) reported that the proposed law on AEDs in Italy was approved by the social affairs commission of the chamber in July 2021.

Furthermore, the global external defibrillators market is driven by various factors like technological advancements, novel product launches, and collaboration with key players will further drive the market growth during the forecast period.

Market Dynamics: Restraint

Product recalls is one of the major factor that hampers the market growth rate during the forecast period. For instance, in July 2023, Medtronic recalled implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillators (crt-ds) with glassed feedthrough for risk of low or no energy output during high voltage therapy.

Also, factors such as stringent regulations and lack of awareness and early corrective measures about Sudden Cardiac Arrest (SAC) may hinder the growth of the market over the forecast period. Moreover, Cybersecurity is another major concern in the defibrillators market. The new generation of implantable defibrillators is technologically advanced, allowing for remote data transfer.

Segment Analysis

The global external defibrillators is segmented based on product type, technology, end-user and region.

The automated external defibrillators segment from the product type accounted for approximately 41.2% of the market share

The automated external defibrillators segment from the product type accounted for 41.2% and it is expected to be dominated during the forecast period. An automated external defibrillator AED is a portable medical device that delivers a shock to the heart through the chest wall in order to restore normal heart rhythm. AEDs are used to treat victims of sudden cardiac arrest (SCA), which is when the heart stops beating unexpectedly. When someone who is suffering from life-threatening arrhythmias goes into sudden cardiac arrest, time is critical.

Automated external defibrillators (AED) are mostly found in public access settings and are meant to be used by non-medical personnel. If someone suffers sudden cardiac arrest, people nearby can provide CPR and use an AED before the ambulance arrives. When turned on, the AED will give the user step-by-step directions to deliver a shock if needed. The person using the AED needs to follow the instructions and the AED will start functioning automatically. This increases the demand for the AED and accelerates the segment's growth.

For instance, in March 2023, Safe Life acquired Coro Medical and AED.us, a national market player in automated external defibrillator (AED) sales and services, to expand life-saving equipment and services across the United States.

Furthermore, in January 2023, Avive Solutions received FDA approval for its Handheld automated external defibrillator with unique capabilities. Avive Connect AED combines cellular and WiFi connectivity, GPS technology, remote maintenance, and extreme portability in the handheld device.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to the supportive regulations to increase the availability of public access AEDs, and the high adoption of external defibrillators at healthcare facilities. Many national organizations in the U.S., including the American Heart Association (AHA), recommend the implementation of comprehensive Public Access Defibrillation (PAD) programs.

For instance, in June 2020, Royal Philips, a global leader in health technology, stated that the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration has granted premarket approval (PMA) for the company's HeartStart FR3 and HeartStart FRx automated external defibrillators (AEDs), and their supporting accessories, including batteries and pads.

COVID-19 Impact Analysis

COVID-19 had a substantial impact on the global external defibrillators market arrhythmias were observed in many COVID patients, but in-hospital defibrillator facilities helped save their lives. Due to the virus outbreak, many surgical procedures were cancelled or postponed, depending on the criticality of the patient. This resulted in losses for companies.

COVID-19 also impacted various stages of the value chain, primarily due to strict lockdowns imposed by the governments of most countries. The turnaround time for the delivery of products and services was also affected due to countries' newer packaging protocols and lockdown measures. All these factors negatively impacted the manufacturing and supply chain of the defibrillators market.

Competitive Landscape

The major global players in the external defibrillators market include: Koninklijke Philips N.V, Advin Health Care, ZOLL Medical Corporation, Defibtech, LLC., Stryker, ClJ Medical System Inc., Avive Solutions, Inc, Schiller AG, MEDIANA Co., Ltd, ViVest Medical Technology Co and among others.

Key Developments

  • In January 2023, Avive Solutions, Inc., received U.S. Food and Drug Administration (FDA) pre-market approval (PMA)-- the agency's highest level of approval- for its Avive AED, a unique automated external defibrillator.
  • In April 2022, Kestra Medical Technologies stated that the company's ASSURE Wearable Cardioverter Defibrillator (WCD) system is effective at reducing false-positive shock alarms according to results of the ASSURE clinical evaluation detection and safety study published in the journal of cardiovascular electrophysiology.

Why Purchase the Report?

  • To visualize the global external defibrillators market segmentation-based product type, technology, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analysing trends and co-development
  • Excel data sheet with numerous data points of external defibrillators market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global external defibrillators market report would provide approximately 69 tables, 70 figures, and 185 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Driver
      • 4.1.1.1. Rise in the prevalence of cardiac arrhythmias
      • 4.1.1.2. Increasing number of supportive policies by governments
    • 4.1.2. Restraints
      • 4.1.2.1. Product recalls
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Automated External Defibrillators *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Manual External Defibrillators
  • 7.4. Wearable Cardioverter Defibrillators

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Monophasic Defibrillation *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Biphasic Defibrillation

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Home Care Services
  • 9.5. Ambulatory Surgical Centers

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Koninklijke Philips N.V
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Advin Health Care
  • 12.3. ZOLL Medical Corporation
  • 12.4. Defibtech, LLC.
  • 12.5. Stryker
  • 12.6. ClJ Medical System Inc.
  • 12.7. Avive Solutions, Inc
  • 12.8. Schiller AG
  • 12.9. MEDIANA Co., Ltd
  • 12.10. ViVest Medical Technology Co

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us